Predictmedix (CSE: PMED | OTCQB: PMEDF) is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients. Our symptom detection products use non-invasive technologies to capture data points from each person walking through our Safe Entry screening units. Within seconds, our products determine if individuals are displaying symptoms of infectious disease, such as Covid-19, or are exhibiting signs of impairment from alcohol or cannabis. Our new AI products in development will give medical professionals tools that empower their decision making for better patient outcomes. To learn more about our products and company, visit Predictmedix.com.